Development of level a in vitro–vivo correlation for electrosprayed microspheres containing leuprolide: physicochemical, pharmacokinetic, and pharmacodynamic evaluation DS Lee, DW Kang, GW Choi, HG Choi, HY Cho Pharmaceutics 12 (1), 36, 2020 | 15 | 2020 |
Pharmacokinetic-pharmacodynamic modeling approach for dose prediction of the optimal long-acting injectable formulation of finasteride DW Kang, CH Ryu, JH Kim, GW Choi, S Kim, CH Chon, HY Cho International Journal of Pharmaceutics 601, 120527, 2021 | 9 | 2021 |
Long-acting injectable donepezil microspheres: Formulation development and evaluation GW Choi, S Lee, DW Kang, JH Kim, HY Cho Journal of Controlled Release 340, 72-86, 2021 | 8 | 2021 |
In vitro and in vivo evaluations of a 3-month sustained-release microsphere depot formulation of leuprolide acetate GY Kim, JH Kim, T Lee, BC Bae, H Baik, T Kim, J Kim, DW Kang, JH Kim, ... Journal of Pharmaceutical Investigation 52 (1), 129-138, 2022 | 6 | 2022 |
Evaluation of lidocaine and metabolite pharmacokinetics in hyaluronic acid injection JH Kim, DW Kang, GW Choi, SB Lee, S Lee, HY Cho Pharmaceutics 13 (2), 203, 2021 | 6 | 2021 |
Gender differences in pharmacokinetics of perfluoropentanoic acid using non-linear mixed-effect modeling in rats GW Choi, EJ Choi, JH Kim, DW Kang, YB Lee, HY Cho Archives of Toxicology 94, 1601-1612, 2020 | 6 | 2020 |
Pre-clinical pharmacokinetic characterization, tissue distribution, and excretion studies of novel edaravone oral prodrug, TEJ-1704 DW Kang, JH Kim, KM Kim, S Cho, HW Jang, JW Chang, SM Dong, ... Pharmaceutics 13 (9), 1406, 2021 | 4 | 2021 |
Parent-metabolite pharmacokinetic modeling of formononetin and its active metabolites in rats after oral administration of formononetin formulations JH Kim, DW Kang, S Cho, HY Cho Pharmaceutics 15 (1), 45, 2022 | 3 | 2022 |
Strategies for developing Alzheimer’s disease treatments: application of population pharmacokinetic and pharmacodynamic models DW Kang, S Cho, GW Choi, HY Cho Journal of Pharmaceutical Investigation 52 (5), 519-538, 2022 | 3 | 2022 |
Application of minimal physiologically-based pharmacokinetic model to simulate lung and trachea exposure of pyronaridine and artesunate in hamsters DW Kang, KM Kim, JH Kim, HY Cho Pharmaceutics 15 (3), 838, 2023 | 2 | 2023 |
Population pharmacokinetic modeling and simulation of choline in healthy Korean subjects after oral administration of choline alfoscerate AG Im, GW Choi, DW Kang, S Cho, J Kim, KY Kim, HY Cho Journal of Pharmaceutical Investigation 52 (3), 331-339, 2022 | 2 | 2022 |
Physiologically-based pharmacokinetic model for evaluating gender-specific exposures of N-nitrosodimethylamine (NDMA) DW Kang, JH Kim, GW Choi, S Cho, HY Cho Archives of Toxicology 98 (3), 821-835, 2024 | 1 | 2024 |
Approaches for estimating the clinical starting dose of new dosage forms: An example of a long-acting injectable formulation of finasteride DW Kang, JH Kim, HY Cho International Journal of Pharmaceutics 631, 122510, 2023 | 1 | 2023 |
Integration of modern science into herbal medicine: application of pharmacokinetic-pharmacodynamic modeling in understanding nonclinical study of Cinnamomum cassia extract. JH Kim, YB Hong, DW Kang, S Cho, HJ Seo, HY Cho Journal of Pharmaceutical Investigation, 1-13, 2024 | | 2024 |
Sex, age, and species differences of perfluorooctanoic acid modeled by flow-versus permeability-limited physiologically-based pharmacokinetic models GW Choi, DW Kang, JH Kim, S Cho, YB Lee, IH Kwon, HY Cho Toxicology 505, 153806, 2024 | | 2024 |
Multicompartmental pharmacokinetic evaluation of enavogliflozin eye drop formulation: Understanding its distribution to posterior segments S Cho, DW Kang, JH Kim, GW Choi, M Kang, HY Cho Journal of Pharmaceutical Investigation, 1-15, 2024 | | 2024 |
Study on the Reliability Improvement of Health Functional Foods: The Regulatory Operation and Management of Institution Conducting Human Study in Korea S Cho, YB Hong, DW Kang, HY Cho Food Supplements and Biomaterials for Health 2 (2), 2022 | | 2022 |